Pfizer, U.S. ink $5.29B deal for possible COVID-19 treatment


While Fizer waits for federal regulators to approve its experimental cope with nineteen treatment hill it's ready to sell millions of courses to the government files arrest the FDA this week to authorize the potential treatment which has been shown to significantly cut hospitalizations and deaths among infected people if regulators approve the pale the governments agreed to buy ten million treatment courses for about five hundred twenty nine dollars each it already had a deal to pay roughly seven hundred dollars each for courses of Merck's competing pill which the FDA is now reviewing Sager made Ghani Washington

Coming up next